Statins for stronger bones? study in spinal injury patients falls short
NCT ID NCT03113994
First seen Apr 17, 2026 · Last updated May 09, 2026 · Updated 3 times
Summary
This study aimed to see if rosuvastatin, a common cholesterol-lowering drug, could help prevent bone loss and reduce heart disease risk in adults with long-term spinal cord injury. Participants were randomly assigned to take either rosuvastatin or a placebo for 12 months, along with calcium, vitamin D, and coenzyme Q10. The study was terminated early and enrolled only 8 of the planned 54 participants, so no firm conclusions can be drawn.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Health Network - Toronto Rehab Lyndhurst Centre
Toronto, Ontario, M4G 3V9, Canada
-
University Of Miami Miller School of Medicine
Miami, Florida, 33136, United States
Conditions
Explore the condition pages connected to this study.